Insider transactions Jaguar Health, Inc.

Stocks

JAGX

US47010C8626

Pharmaceuticals

Delayed Nasdaq Other stock markets 09:48:25 15/07/2026 pm IST			5-day change	1st Jan Change
2.110 ^USD	-2.76%		-14.93%	-93.71%

25/06	Jaguar Health, Inc., Napo Pharmaceuticals, Inc., And Woodward Specialty LLC Amend Manufacturing And Supply Agreement	CI
24/06	Jaguar Health Initiates Strategic-Alternatives Review Ahead of Crofelemer NDA Filing for Rare Intestinal Failure Program	CI

Insider Transaction History

Latest insider transactions for Jaguar Health, Inc.

Date	Insider	Type	Main position	Quantity	Price	Amount	% Market Cap.
11/12	Jonathan Siegel	Free	Director	14,754	-	-	0.3949%
11/12	Steven King	Free	Executive/Senior Manager	23,480	-	-	0.6285%
11/12	Anula Kusum Jayasuriya	Free	Director	11,740	-	-	0.3143%
11/12	Carol Lizak	Free	Chief Financial Officer	23,480	-	-	0.6285%
11/12	Jonathan Wolin	Free	Compliance Officer	23,480	-	-	0.6285%
11/12	Pravin Ramsewak Chaturvedi	Free	Chief Technology Officer	23,480	-	-	0.6285%
11/12	John Micek	Free	Director	14,754	-	-	0.3949%
11/12	Lisa Conte	Free	Founder	57,184	-	-	1.5307%
11/12	James Bochnowski	Free	Chairman	12,726	-	-	0.3406%
24/25/24	Pravin Ramsewak Chaturvedi	Issuer sale	Chief Technology Officer	14,689	-	-	1.1615%
24/25/24	James Bochnowski	Issuer sale	Chairman	1,10,176	-	-	8.7119%
24/25/24	Lisa Conte	Issuer sale	Founder	36,724	-	-	2.9039%
24/25/24	John Micek	Issuer sale	Director	36,724	-	-	2.9039%
24/25/24	Jonathan Wolin	Issuer sale	Compliance Officer	36,724	-	-	2.9039%
24/25/24	Jonathan Siegel	Issuer sale	Director	36,724	-	-	2.9039%
24/25/24	Steven King	Issuer sale	Executive/Senior Manager	14,689	-	-	1.1615%
17/25/17	Steven King	Fiscal year	Executive/Senior Manager	2	-	-	0.0002%
17/25/17	Lisa Conte	Fiscal year	Founder	4	-	-	0.0003%
31/25/31	John Micek	Buy	Director	18,000	-	-	0.1103%
31/25/31	Jonathan Wolin	Buy	Compliance Officer	18,000	-	-	0.1103%
31/25/31	Pravin Ramsewak Chaturvedi	Buy	Chief Technology Officer	7,200	-	-	0.0441%
31/25/31	James Bochnowski	Buy	Chairman	54,004	-	-	0.3310%
31/25/31	Jonathan Siegel	Buy	Director	18,000	-	-	0.1103%
31/25/31	Steven King	Buy	Executive/Senior Manager	7,200	-	-	0.0441%
31/25/31	Lisa Conte	Buy	Founder	18,000	-	-	0.1103%
31/25/31	Carol Lizak	Buy	Chief Financial Officer	10,800	-	-	0.0662%
08/24/08	John Micek	Free	Director	26,500	-	-	0.2868%
08/24/08	James Bochnowski	Free	Chairman	23,200	-	-	0.2510%
08/24/08	Pravin Ramsewak Chaturvedi	Free	Chief Technology Officer	44,298	-	-	0.4794%
08/24/08	Jonathan Wolin	Free	Compliance Officer	44,298	-	-	0.4794%
08/24/08	Steven King	Free	Executive/Senior Manager	44,298	-	-	0.4794%
08/24/08	Jonathan Siegel	Free	Director	26,500	-	-	0.2868%
08/24/08	Carol Lizak	Free	Chief Financial Officer	38,520	-	-	0.4168%
08/24/08	Anula Kusum Jayasuriya	Free	Director	21,000	-	-	0.2272%
08/24/08	Lisa Conte	Free	Founder	1,48,523	-	-	1.6072%
17/24/17	Lisa Conte	Fiscal year	Founder	5,390	-	-	0.0020%
17/24/17	Carol Lizak	Fiscal year	Chief Financial Officer	862	-	-	0.0003%
17/24/17	Jonathan Wolin	Fiscal year	Compliance Officer	1,742	-	-	0.0006%
17/24/17	Pravin Ramsewak Chaturvedi	Fiscal year	Chief Technology Officer	1,742	-	-	0.0006%
17/24/17	Steven King	Fiscal year	Executive/Senior Manager	1,224	-	-	0.0004%
05/24/05	Jonathan Wolin	Fiscal year	Compliance Officer	178	-	-	0.0001%
05/24/05	Steven King	Fiscal year	Executive/Senior Manager	356	-	-	0.0002%
05/24/05	Pravin Ramsewak Chaturvedi	Fiscal year	Chief Technology Officer	268	-	-	0.0001%
05/24/05	Carol Lizak	Fiscal year	Chief Financial Officer	120	-	-	0.0001%
05/24/05	Lisa Conte	Fiscal year	Founder	1,200	-	-	0.0006%
14/23/14	Jonathan Siegel	Free	Director	68,568	-	-	0.3589%
14/23/14	Pravin Ramsewak Chaturvedi	Free	Chief Technology Officer	2,04,192	-	-	1.0688%
14/23/14	John Micek	Free	Director	68,568	-	-	0.3589%
14/23/14	James Bochnowski	Free	Chairman	76,613	-	-	0.4010%
14/23/14	Carol Lizak	Free	Chief Financial Officer	1,42,088	-	-	0.7437%